A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation

Toxins (Basel). 2022 Oct 22;14(11):723. doi: 10.3390/toxins14110723.

Abstract

Snakebite envenoming is a neglected tropical disease (NTD) that results from the injection of snake venom of a venomous snake into animals and humans. In Africa (mainly in sub-Saharan Africa), over 100,000 envenomings and over 10,000 deaths per annum from snakebite have been reported. Difficulties in snakebite prevention and antivenom treatment are believed to result from a lack of epidemiological data and underestimated figures on snakebite envenoming-related morbidity and mortality. There are species- and genus-specific variations associated with snake venoms in Africa and across the globe. These variations contribute massively to diverse differences in venom toxicity and pathogenicity that can undermine the efficacy of adopted antivenom therapies used in the treatment of snakebite envenoming. There is a need to profile all snake venom proteins of medically important venomous snakes endemic to Africa. This is anticipated to help in the development of safer and more effective antivenoms for the treatment of snakebite envenoming within the continent. In this review, the proteomes of 34 snake venoms from the most medically important snakes in Africa, namely the Viperidae and Elipdae, were extracted from the literature. The toxin families were grouped into dominant, secondary, minor, and others based on the abundance of the protein families in the venom proteomes. The Viperidae venom proteome was dominated by snake venom metalloproteinases (SVMPs-41%), snake venom serine proteases (SVSPs-16%), and phospholipase A2 (PLA2-17%) protein families, while three-finger toxins (3FTxs-66%) and PLA2s (16%) dominated those of the Elapidae. We further review the neutralisation of these snake venoms by selected antivenoms widely used within the African continent. The profiling of African snake venom proteomes will aid in the development of effective antivenom against snakebite envenoming and, additionally, could possibly reveal therapeutic applications of snake venom proteins.

Keywords: antivenom; elapids; proteomics; snake venom; toxins; venomics; viperids.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Africa South of the Sahara
  • Animals
  • Antivenins / pharmacology
  • Antivenins / therapeutic use
  • Elapid Venoms / toxicity
  • Elapidae / metabolism
  • Humans
  • Proteome / metabolism
  • Proteomics / methods
  • Snake Bites* / drug therapy
  • Snake Venoms / toxicity
  • Viperidae* / metabolism

Substances

  • Antivenins
  • Elapid Venoms
  • Proteome
  • Snake Venoms

Grants and funding

South African National Research Foundation, grant number 137972.